Dr. Amartej Merla, MD

Dr. Merla practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Merla's NPI, 1902097744, was assigned on August 7, 2007. Dr. Merla graduated from Andhra Medical College NTR in 2002. Dr. Merla holds California license 143527.

Dr. Merla's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (626) 256-4673.

Dr. Merla's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Merla is also affiliated with Antelope Valley Medical Center. The medical group on file is City of Hope. Dmand AI also links Dr. Merla to 3 more hospitals, 1 group practice or clinic and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Merla practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Merla's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Merla is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Merla's licenses on file in 5 states: California, New York, New Jersey, Missouri and Pennsylvania.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances, lung cancer and lymphoma among the conditions Dr. Merla treats.

CMS data shows 59,378 Medicare services from Dr. Merla across 38 procedure codes in 2024, for 700 Medicare patients. Medicare paid $923,366 for them.

CMS counts 700 Medicare patients who saw Dr. Merla in 2024. The largest group is 65 to 74, with 307 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Merla's median patient age at 69, with 52% women.

In 2024, Dr. Merla wrote 688 Medicare Part D claims for 132 patients. 79% of them were for generic drugs. CMS names the drug for 452 of them, across 14 drugs with 11 or more claims each, at $723,120 in total drug cost. In 2023, CMS named 357 claims across 15 drugs.

Dr. Merla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Merla as offering telehealth.

Dmand AI links 12 papers to Dr. Merla, published from 2012 to 2023. 2022 was the busiest year, with 3. The most frequent topics are Lung Neoplasms, Molecular Targeted Therapy and Tobacco Use Disorder. Dr. Merla has published most often in J Clin Med. Dr. Merla's most frequent co-authors are Tingting Tan, MD, PhD, Cary A. Presant, MD and Arya Amini, MD.

CMS Open Payments shows 149 general payments to Dr. Merla from 29 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 55% of the total. Celgene Corporation paid the most, $2,462.

Dr. Merla graduated from Andhra Medical College NTR in 2002.

Dr. Merla is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.